Supplementary Figures 1-2, Supplementary Tables 1-2 from p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

Autor: Mihaela Cristea, Don J. Diamond, Joshua D.I. Ellenhorn, Sharon Wilczynski, Melissa Eng, Raechelle Tinsley, Vincent Chung, Robert Morgan, Lucille Leong, Teodora Kaltcheva, Ferdynand Kos, Weimin Tsai, Julie Kilpatrick, Christopher Ruel, Paul Frankel, Nicola R. Hardwick
Rok vydání: 2023
Popis: Figure S1: Frequency of Tregs does not significantly decline post treatment and does not correlate with p53-reactivity or PFS.; Figure S2: Frequency of MDSC does not significantly differ to healthy controls, does not decline post treatment and does not correlate with p53-reactivity or PFS.; Supplementary Table T1: Multi variation analysis* shows an association between progression free survival and frequency of p53-reactive T cells, disease stage and baseline MDSC. Supplementary Table T2: Correlations (Pearson) of variables included in multi variation analysis.
Databáze: OpenAIRE